Dismissal Of Investor Suit Against Hepatitis B Drug Maker Upheld On Appeal

Mealey's (July 26, 2019, 12:18 PM EDT) -- SAN FRANCISCO — A lead plaintiff in a securities class action lawsuit against a drug company and three of its senior executives has failed to plead falsity and scienter in making...
To view the full article, register now.